Search Results

There are 4082 results for: content related to: Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases

  1. You have free access to this content
    Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    Journal of Bone and Mineral Research

    Volume 30, Issue 1, January 2015, Pages: 3–23, Aliya A Khan, Archie Morrison, David A Hanley, Dieter Felsenberg, Laurie K McCauley, Felice O'Ryan, Ian R Reid, Salvatore L Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M Cheung, Suzanne N Morin, Basel Masri, Cyrus Cooper, Sarah L Morgan, Barbara Obermayer-Pietsch, Bente L Langdahl, Rana Al Dabagh, K. Shawn Davison, David L Kendler, George K Sándor, Robert G Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D Pierroz, Riad Sulimani, Deborah P Saunders, Jacques P Brown, Juliet Compston and on behalf of the International Task Force on Osteonecrosis of the Jaw

    Article first published online : 26 DEC 2014, DOI: 10.1002/jbmr.2405

  2. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  3. Denosumab for the Treatment of Osteoporosis and Cancer-Related Conditions

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 123–133, E M Lewiecki and J P Bilezikian

    Article first published online : 7 DEC 2011, DOI: 10.1038/clpt.2011.268

  4. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

    Internal Medicine Journal

    Volume 39, Issue 5, May 2009, Pages: 304–316, M. Dickinson, H. M. Prince, S. Kirsa, A. Zannettino, S. D. J. Gibbs, L. Mileshkin, J. O'Grady, J. F. Seymour, J. Szer, N. Horvath and D. E. Joshua

    Article first published online : 3 NOV 2008, DOI: 10.1111/j.1445-5994.2008.01824.x

  5. You have free access to this content
    Final 5-year results of Z-FAST trial

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Article first published online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  6. Osteonecrosis of the Jaw in Patients Receiving Intravenous or Oral Bisphosphonates

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 5, May 2008, Pages: 667–677, Dr. Amber E. King and Dr. Elena M. Umland

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.5.667

  7. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 47–54, Ana O. Hoff, Bela Toth, Mimi Hu, Gabriel N. Hortobagyi and Robert F. Gagel

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05771.x

  8. You have free access to this content
    Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis

    Journal of Bone and Mineral Research

    Volume 27, Issue 10, October 2012, Pages: 2130–2143, J Ignacio Aguirre, Mohammed P Akhter, Donald B Kimmel, Jennifer E Pingel, Alyssa Williams, Marda Jorgensen, Lakshmyya Kesavalu and Thomas J Wronski

    Article first published online : 18 SEP 2012, DOI: 10.1002/jbmr.1669

  9. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  10. Jaw Bone Samples From Bisphosphonate-Treated Patients: A Pilot Cohort Study

    Clinical Implant Dentistry and Related Research

    Volume 17, Issue S2, October 2015, Pages: e679–e691, Carina Cardemil, Peter Thomsen and Cecilia Larsson Wexell

    Article first published online : 27 APR 2015, DOI: 10.1111/cid.12307

  11. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw

    Journal of Oral Pathology & Medicine

    Volume 39, Issue 5, May 2010, Pages: 390–396, Matteo Biasotto, Silvia Chiandussi, Serena Zacchigna, Silvia Moimas, Franca Dore, Gabriele Pozzato, Fabio Cavalli, Fabrizio Zanconati, Luca Contardo, Mauro Giacca and Roberto Di Lenarda

    Article first published online : 28 FEB 2010, DOI: 10.1111/j.1600-0714.2009.00878.x

  12. You have free access to this content
    Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

    Journal of Bone and Mineral Research

    Volume 23, Issue 6, June 2008, Pages: 826–836, Ana O Hoff, Béla B Toth, Kadri Altundag, Marcella M Johnson, Carla L Warneke, Mimi Hu, Ajay Nooka, Gilbert Sayegh, Valentina Guarneri, Kimberly Desrouleaux, Jeffrey Cui, Andrea Adamus, Robert F Gagel and Gabriel N Hortobagyi

    Article first published online : 4 FEB 2008, DOI: 10.1359/jbmr.080205

  13. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice

    Journal of Bone and Mineral Research

    Volume 30, Issue 9, September 2015, Pages: 1627–1640, Rafael Scaf de Molon, Hiroaki Shimamoto, Olga Bezouglaia, Flavia Q Pirih, Sarah M Dry, Paul Kostenuik, Rogely W Boyce, Denise Dwyer, Tara L Aghaloo and Sotirios Tetradis

    Article first published online : 27 MAY 2015, DOI: 10.1002/jbmr.2490

  14. You have full text access to this OnlineOpen article
    Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

    Cancer Science

    Volume 105, Issue 8, August 2014, Pages: 989–995, Haruyasu Murakami, Takeharu Yamanaka, Takashi Seto, Kenji Sugio, Isamu Okamoto, Toshiyuki Sawa, Tomonori Hirashima, Koji Takeda, Shinji Atagi, Masahiro Fukuoka, Yoichi Nakanishi, Kazuhiko Nakagawa and Nobuyuki Yamamoto

    Article first published online : 12 JUL 2014, DOI: 10.1111/cas.12448

  15. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  16. The use of zoledronic acid in pediatric cancer patients

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 610–614, Keith J. August, Amanda Dalton, Howard M. Katzenstein, Bradley George, Thomas A. Olson, Karen Wasilewski-Masker and Louis B. Rapkin

    Article first published online : 23 DEC 2010, DOI: 10.1002/pbc.22681

  17. Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption

    Drug Development Research

    Volume 55, Issue 4, April 2002, Pages: 210–224, Jonathan R. Green and Michael J. Rogers

    Article first published online : 21 JUN 2002, DOI: 10.1002/ddr.10071

  18. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 9, October 2012, Pages: 713–720, Somying Patntirapong, Weerachai Singhatanadgit, Chatvadee Chanruangvanit, Kwankamol Lavanrattanakul and Yodhathai Satravaha

    Article first published online : 5 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01154.x

  19. You have free access to this content
    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

    Journal of Bone and Mineral Research

    Volume 26, Issue 9, September 2011, Pages: 2261–2270, Ian R Reid, Kenneth Lyles, Guoqin Su, Jacques P Brown, John P Walsh, Javier del Pino-Montes, Paul D Miller, William D Fraser, Susan Cafoncelli, Christina Bucci-Rechtweg and David J Hosking

    Article first published online : 19 AUG 2011, DOI: 10.1002/jbmr.438

  20. You have free access to this content
    Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis

    BJU International

    Volume 109, Issue 3, February 2012, Pages: 394–400, Kouji Izumi, Atsushi Mizokami, Shingo Itai, Takashi Shima, Kazuyoshi Shigehara, Sotaro Miwa, Yuji Maeda, Hiroyuki Konaka, Eitetsu Koh and Mikio Namiki

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10192.x